Gregory Conn
Directeur Technique/Scientifique/R&D chez PDS BIOTECHNOLOGY CORPORATION
Fortune : 376 677 $ au 30/04/2024
Postes actifs de Gregory Conn
Sociétés | Poste | Début | Fin |
---|---|---|---|
PDS BIOTECHNOLOGY CORPORATION | Directeur Technique/Scientifique/R&D | 15/03/2019 | - |
Historique de carrière de Gregory Conn
Anciens postes connus de Gregory Conn
Sociétés | Poste | Début | Fin |
---|---|---|---|
Covance Biotechnology Services, Inc.
Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01/01/1998 | 01/01/2000 |
PDS Operating Corp.
PDS Operating Corp. BiotechnologyHealth Technology PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ. | Directeur Technique/Scientifique/R&D | - | - |
Fondateur | - | - |
Formation de Gregory Conn
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Founder | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
PDS BIOTECHNOLOGY CORPORATION | Health Technology |
Entreprise privées | 2 |
---|---|
PDS Operating Corp.
PDS Operating Corp. BiotechnologyHealth Technology PDS Operating Corp. operates as a biopharmaceutical company. It develops immunotherapies for cancer and infectious disease. The firm’s versamune is capable of potent activation of immune cells without the side effects of traditional vaccines, efficiently delivering disease related antigen targets to the immune system and promoting antigen processing to present antigen appropriately to generate both strong prophylactic and therapeutic immune responses to disease. The company was founded by Frank K. Bedu-Addo and Gregory L. Conn and is headquartered in Princeton, NJ. | Health Technology |
Covance Biotechnology Services, Inc.
Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Covance Biotechnology Services, Inc. develops pharmaceutical products. The company offers two microbiology laboratories, one for mycoplasma analysis, and a second for molecular biology. It provides services to biomolecules, including recombinant proteins, monoclonal antibodies, vaccines, blood products, and gene therapy products. The company was founded by Richard J. Hawkins, V. Bryan Lawlis, and John A. Scarlett in 1995 and is headquartered in Princeton, NJ. | Health Technology |
- Bourse
- Insiders
- Gregory Conn
- Expérience